{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T15:30:34Z","timestamp":1788363034209,"version":"build-2803163510"},"reference-count":6,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[1991,3,1]],"date-time":"1991-03-01T00:00:00Z","timestamp":667785600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Infection"],"published-print":{"date-parts":[[1991,3]]},"DOI":"10.1007\/bf01645578","type":"journal-article","created":{"date-parts":[[2005,5,7]],"date-time":"2005-05-07T17:16:29Z","timestamp":1115486189000},"page":"106-109","source":"Crossref","is-referenced-by-count":10,"title":["Comparative in vitro activities of amoxicillin-clavulanate, ampicillin-sulbactam and piperacillin-tazobactam against strains of escherichia coli and proteus mirabilis harbouring known \u03b2-lactamases","Vergleich der In-vitro-Aktivit\u00e4ten von Amoxicillin-Clavulans\u00e4ure, Ampicillin-Sulbactam und Piperacillin-Tazobactam gegen\u00fcber St\u00e4mmen von Escherichia coli und Proteus mirabilis mit bekannten \u03b2-Laktamasen"],"prefix":"10.1007","volume":"19","author":[{"given":"S.","family":"Gatermann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Marre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1128\/AAC.33.8.1268","volume":"33","author":"R. J. Fass","year":"1989","unstructured":"Fass, R. J., Prior, R. B. Comparativein vitro activities of piperacillin-tazobactam and ticarcillin-clavulanate. Antimicrob. Agents Chemother. 33 (1989) 1268\u20131274.","journal-title":"Antimicrob. Agents Chemother."},{"key":"CR2","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1128\/AAC.29.6.980","volume":"29","author":"M. R. Jacobs","year":"1986","unstructured":"Jacobs, M. R., Aronoff, S. C., Johenning, S., Shlaes, D. M., Yamanabe, S. Comparative activities of the \u03b2-lactamase inhibitors YTR830, clavulanate, and sulbactam combined with ampicillin and broad-spectrum penicillins against defined \u03b2-lactamase-producing aerobic gram-negative bacilli. Antimicrob. Agents Chemother. 29 (1986) 980\u2013985.","journal-title":"Antimicrob. Agents Chemother."},{"key":"CR3","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1128\/AAC.29.5.955","volume":"29","author":"L. Gutmann","year":"1986","unstructured":"Gutmann, L., Kitzis, M. D., Yamabe, S., Acar, J. F. Comparative evaluation of a new \u03b2-lactamase inhibitor, YTR830, combined with different \u03b2-lactam antibiotics against bacteria harboring known \u03b2-lactamases. Antimicrob. Agents Chemother. 29 (1986) 955\u2013957.","journal-title":"Antimicrob. Agents Chemother."},{"key":"CR4","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/BF01969534","volume":"1","author":"R. Marre","year":"1990","unstructured":"Marre, R., Aleksic, S. Beta-lactamase types and beta-lactam resistance ofEscherichia coli strains with chromosomally-mediated ampicillin resistance. Eur. J. Clin. Microbiol. Inf. Dis. 1 (1990) 44\u201346.","journal-title":"Eur. J. Clin. Microbiol. Inf. Dis."},{"key":"CR5","first-page":"287","volume":"A 258","author":"R. Marre","year":"1984","unstructured":"Marre, R., Borner, K., Schulz, E. Different mechanisms of TEM-1 and Oxa-1 mediated resistance to piperacillin inE. coli. Zentralbl. Bakteriol. Hyg. A 258 (1984) 287\u2013295.","journal-title":"Zentralbl. Bakteriol. Hyg."},{"key":"CR6","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1093\/jac\/25.4.567","volume":"25","author":"F. Higashitani","year":"1990","unstructured":"Higashitani, F., Hyodo, A., Ishida, N., Inoue, M., Mitsuhashi, S. Inhibition of \u03b2-lactamases by tazobactam andin-vitro antibacterial activity of tazobactam combined with piperacillin. J. Antimicrob. Chemother. 25 (1990) 567\u2013574.","journal-title":"J. Antimicrob. Chemother."}],"container-title":["Infection"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01645578.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01645578\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01645578","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,7]],"date-time":"2019-05-07T12:32:56Z","timestamp":1557232376000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01645578"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1991,3]]},"references-count":6,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1991,3]]}},"alternative-id":["BF01645578"],"URL":"https:\/\/doi.org\/10.1007\/bf01645578","relation":{},"ISSN":["0300-8126","1439-0973"],"issn-type":[{"value":"0300-8126","type":"print"},{"value":"1439-0973","type":"electronic"}],"subject":[],"published":{"date-parts":[[1991,3]]}}}